3 Beaten-Down AI Chip Stocks Worth a Closer Look After the Sell-Off

Nvidia reported fiscal Q1 revenue of $81.6 billion, up 85% year over year, while guiding fiscal Q2 revenue to about $91 billion, implying roughly 95% growth; AMD projected second-quarter revenue growth to accelerate to about 46% year over year, and Broadcom delivered 48% revenue growth with AI chip revenue surging 143% to $10.8 billion. Despite these strong fundamentals, all three stocks sold off sharply on valuation and sentiment concerns, with Nvidia down about 18% from its 52-week high, AMD down about 17% from its June 3 record, and Broadcom down about 20% in a week. The article argues the pullback may create a long-term buying opportunity, though it flags high valuations and slowing AI spending as risks.

Analysis

The selloff looks less like a demand shock and more like a positioning unwind in the highest-multiple part of the AI stack. That matters because when crowded long exposure de-risks, the first-order pain hits the leaders, but the second-order opportunity often shifts to suppliers with more leverage to capex cadence than to end-market sentiment. The key question for the next 1-2 quarters is not whether AI spend slows in absolute terms, but whether hyperscalers pause orders long enough to break momentum in revision estimates.

NVDA still screens as the cleanest fundamental story, but at this scale the stock trades more like a duration asset than a semiconductor name: the multiple is now sensitive to any sign that growth normalizes from extremely elevated levels. AMD is the more asymmetric operating story, yet also the most fragile from a valuation standpoint because its rerating has already discounted a credible share-gain path; any delay in rack-scale execution or launch slip would hit the stock harder than a modest guide beat would lift it. AVGO is the most interesting contrarian: margin compression from mix shift is a feature, not a bug, if it is buying share in a market where customers care more about system-level throughput and time-to-deploy than gross margin purity.

The consensus appears to be underestimating how much of the near-term volatility is mechanical rather than fundamental. If AI capex remains intact, a stabilizing order book should quickly reverse sentiment because these names are owned for scarcity and earnings revision momentum, not just current-quarter growth. The real risk is a 2-3 month digestion period where hyperscaler procurement pauses, causing narrative damage even if annual spending plans remain unchanged.

Key Decisions for Investors

• Initiate a staged long NVDA position over the next 2-4 weeks, adding only on further drawdowns or a confirmation of hyperscaler order stability; upside is a re-rating back toward prior multiples if forward growth holds, downside is limited if capex merely flatlines rather than contracts.
• Prefer long AVGO over long AMD for a 3-6 month trade: AVGO has more direct exposure to AI buildout monetization and less valuation fragility than AMD, while AMD needs multiple execution milestones to justify current expectations.
• Set up a pair trade: long NVDA / short AMD for 1-2 quarters. This expresses the view that quality and near-term earnings certainty should outperform a more execution-sensitive rerating story if AI spend remains robust but less euphoric.
• Avoid adding fresh risk in AMD until there is evidence that rack-scale deployments are translating into repeatable revenue acceleration; the stock likely needs another clean guide-up before it can sustain a higher multiple.
• Use any further weakness in AVGO to initiate a partial position with a 6-12 month horizon; if management eventually raises its AI revenue outlook, the stock can re-rate sharply, but the current setup warrants scaling rather than all-in sizing.